News : 2012

David Watkins, Ph.D.

Nature Study Pinpoints Mechanism that Controls AIDS in Rare Cases

A Miller School researcher and his team have discovered how a rare, few people infected with HIV fight off AIDS without taking antiretroviral drugs, a finding that may bring scientists a step closer to developing a vaccine for HIV/AIDS.

Read more »

Marie Valdés-Dapena, M.D.

Pediatric Pathology Icon Passes Away

Pediatric pathology pioneer Marie Valdés-Dapena, M.D., professor emerita of pathology and pediatrics, passed away September 30. She was 91.

Read more »

David Watkins, Ph.D.

Dr. David Watkins Awarded $10 Million Grant to Develop HIV Vaccine

David Watkins, Ph.D., professor and vice chair of research in the Department of Pathology, has been awarded a $9.9 million grant from the National Institute of Allergy and Infectious Diseases to develop an HIV vaccine.

Read more »

Richard J. Cote, M.D.

Macdonald Foundation Gift Creates Collaborative Institute in Biomedical Nanotechnology

Propelled by a transformative gift from a longtime contributor, the University of Miami announced on March 27 the creation of the Dr. John T. Macdonald Foundation Biomedical Nanotechnology Institute, a collaboration of key scientific disciplines that will harness the field of nanotechnology for clinical applications.

Read more »

Sylvia Daunert, Ph.D., top, Robert Langer, Sc.D., left, and George Whitesides, Ph.D.

Nanotechnology Experts Gather for 45th Miami Winter Symposium

In its 45th year, the renowned Miami Winter Symposium focused on “Nanotechnology in Biomedicine” this year, drawing biotechnology and nanotechnology luminaries—including 2008 Nobel laureate Roger Tsien, Ph.D., as well as members of the U.S. national academies—to South Florida to discuss the latest advancements in the two fields that are fueling cross-collaborations, challenges, and new discoveries.

Read more »

David Watkins, Ph.D.

Pathologist Joins Faculty to Focus on AIDS and Dengue Fever Vaccines

David Watkins, Ph.D., an accomplished investigator studying the mechanisms of viral evasion from the immune system, has joined the Miller School faculty as professor and vice chair of research in the Department of Pathology

Read more »

Andrew V. Schally, Ph.D., M.D.h.c., D.Sc.h.c., left, and Norman Block, M.D.

Islet Function Improved with Enhanced Oxygen and GHRH Agonist in Bioartificial Pancreas

An international collaborative study with Miller School researchers has uncovered a key strategy that may provide a promising avenue for future approaches to islet transplantation that would open this treatment to a greater number of patients with diabetes.

Read more »

Richard J. Cote, M.D., seated, accepts the first Joseph R. Coulter, Jr. Endowed Chair in Pathology surrounded by, from left, his son Nicholas, wife Anne, daughter Juliet, Dean Pascal J. Goldschmidt, M.D., and daughter Grace.

Richard Cote, M.D., Named First Joseph R. Coulter, Jr. Endowed Chair in Pathology

Richard J. Cote, M.D., professor and chair of the Department of Pathology, chief of service at Jackson Memorial Hospital, and director of the Biomedical Nanotechnology Institute at the University of Miami (BioNIUM), accepted the Joseph R. Coulter, Jr. Endowed Chair in Pathology at a January 26 ceremony at the Miller School’s Clinical Research Building.

Read more »

Ram H. Datar, M.Phil., Ph.D.

Dr. Ram H. Datar Receives Prestigious Jewel of India Award

Ram H. Datar, M.Phil., Ph.D., associate professor of pathology and biochemistry and molecular biology, has received the 2012 Hind Rattan Award, also known as the Jewel of India award, in recognition of outstanding services, achievements and contributions that bring honor to his native India.

Read more »

Ferenc Rick, M.D., Ph.D., Andrew Schally, Ph.D., M.D.h.c., D.Sc.h.c., and Norman Block, M.D.

Stimulation of GHRH Action May Improve Pneumonia Survival

Miller School scientists are part of an international research team that may have found a way to block a second wave of death that can result from pneumonia treatment.

Read more »

Ferenc Rick, M.D., Ph.D., Andrew Schally, Ph.D., M.D.h.c., D.Sc.h.c., and Norman Block, M.D.

Antagonists of Growth Hormone-Releasing Hormone Inhibit Advanced Prostate Cancer

A team of Miller School physician-scientists has demonstrated that an antagonist of growth hormone-releasing hormone (GHRH) has the ability to suppress the progression of late stage prostate cancer.

Read more »